Dated disclosed rounds · latest 2021-11-01
Series B
Quell Therapeutics
Cell therapy (engineered T-regulatory cells)
VerifiedSeries BLondon
- Companies House
- 11890040
- GLEIF LEI
- 2138003MLPFKHCR6UX19
- Latest evidence
- 2021-11-01
- Evidence snapshot
- 2026-08-25
Exact award notices · latest No exact award match
2026-08-01
Jun 2026
Signals organise dated evidence; they do not score growth, revenue, creditworthiness or investment performance.
Evidence timeline
5 dated observations
Funding, procurement, registry and identifier records are placed on one chronology. Each row says whether it is a source fact, a record observation or reference metadata; no inferred event is inserted.
RegistryRecord observation Status observed: Active
Snapshot evidence only; this row does not claim the status changed on this date.
IdentifierReference metadata LEI record updated
2138003MLPFKHCR6UX19 · registration ISSUED
FundingSource fact Series B
$156M · 5 named investors
IdentifierReference metadata LEI first registered
2138003MLPFKHCR6UX19
RegistryRegistry fact Company incorporated
QUELL THERAPEUTICS LIMITED · company 11890040
Latest disclosed round
Series B
- Date
- 2021-11-01
- Amount
- USD 156m
- Sector
- Biotech & techbio
- Companies House
- 11890040
- ONS region
- London
Evidence status
Directory ready
- Identity
- Verified
- Match
- High — exact company number and aligned registered name
- Operating status
- active
- Data origins
- Core directory, Growth Network, Live Chris T D1
Capital network
7 linked investors
Lead, participant, lender and other retained roles remain distinct where the source supports them. Every relationship below names its source layer, observation date, match method and publication state.
Fidelity Management & Research CompanyleadFidelity Management and Research CompanyleadJeito CapitalleadRidgeback Capital InvestmentsleadSV Health InvestorsleadAlbionVCparticipantSynconaparticipant
| Investor | Role | Date | Source | Match / state |
|---|---|---|---|---|
| Fidelity Management & Research Company | lead | 2021-11-01 | PR Newswire ↗ · Insideprecisionmedicine ↗ | reviewed canonical company and investor alias resolutionsource-linked · published |
| Fidelity Management and Research Company | lead | 2021-11-01 | PR Newswire ↗ · Insideprecisionmedicine ↗ | reviewed canonical company and investor alias resolutionsource-linked · published |
| Jeito Capital | lead | 2021-11-01 | PR Newswire ↗ · Insideprecisionmedicine ↗ | reviewed canonical company and investor alias resolutionsource-linked · published |
| Ridgeback Capital Investments | lead | 2021-11-01 | PR Newswire ↗ · Insideprecisionmedicine ↗ | reviewed canonical company and investor alias resolutionsource-linked · published |
| SV Health Investors | lead | 2021-11-01 | PR Newswire ↗ · Insideprecisionmedicine ↗ | reviewed canonical company and investor alias resolutionsource-linked · published |
| AlbionVC | participant | 2026-08-25 | Vc ↗ | reviewed canonical company and investor alias resolutionsource-linked · published |
| Syncona | participant | 2021-11-01 | PR Newswire ↗ · Insideprecisionmedicine ↗ | reviewed canonical company and investor alias resolutionsource-linked · published |
Funding record
1 disclosed round
Open a dated round to move directly between the company, named investors and source publication.
| Date | Stage | Amount | Investors | Named sources |
|---|---|---|---|---|
| 2021-11-01 | Series B | $156M | Jeito Capital · Ridgeback Capital Investments · SV Health Investors · Fidelity Management & Research Company · Syncona | PR Newswire ↗ · Insideprecisionmedicine ↗ |
Companies House status and filing snapshot
QUELL THERAPEUTICS LIMITED
Exact company-number match from the public register. The retained status is active. Filing dates and SIC codes are registry context, not a credit or investment-quality assessment.
Registered record
- Status
- Active
- Company type
- Private Limited Company
- Country of origin
- United Kingdom
- Incorporated
- 2019-03-19
- Dissolved
- Not applicable
- Company number
- 11890040
Filing context
- Accounts category
- FULL
- Accounts made up to
- 2025-12-31
- Next accounts due
- 2027-09-30
- Confirmation made up to
- 2026-04-28
- Registry snapshot
- 2026-08-01
- Live check
- Bulk snapshot only
72110Research and experimental development on biotechnology
Global legal-entity identifier
2138003MLPFKHCR6UX19
Exact company-number match to the GLEIF golden-copy data. An LEI is an identifier for a legal entity; it is not a credit, risk or investment-quality rating.
GLEIF record
- Legal name
- QUELL THERAPEUTICS LIMITED
- Entity status
- ACTIVE
- Jurisdiction
- GB
- Registration status
- ISSUED
- Last updated
- 2025-09-08T14:12:07.090Z
- Next renewal
- 2026-10-07T00:00:00Z
Traceability
Source trail
Funding and investor claims retain named public-source links. This is a dated research snapshot, not a live cap table.